0001209191-13-044107.txt : 20130912
0001209191-13-044107.hdr.sgml : 20130912
20130912200024
ACCESSION NUMBER: 0001209191-13-044107
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120511
FILED AS OF DATE: 20130912
DATE AS OF CHANGE: 20130912
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEI Pharma, Inc.
CENTRAL INDEX KEY: 0001262104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510407811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 11975 EL CAMINO REAL
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-792-6300
MAIL ADDRESS:
STREET 1: 11975 EL CAMINO REAL
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MARSHALL EDWARDS INC
DATE OF NAME CHANGE: 20030902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rueckert William Dodge
CENTRAL INDEX KEY: 0001380016
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50484
FILM NUMBER: 131095132
MAIL ADDRESS:
STREET 1: 175 CASSIA WAY, SUITE 115
CITY: HENDERSON
STATE: NV
ZIP: 89014
4/A
1
c596599_4ax0.xml
MAIN DOCUMENT DESCRIPTION
X0306
4/A
2012-05-11
2012-05-15
0001262104
MEI Pharma, Inc.
MEIP
0001380016
Rueckert William Dodge
C/O MEI PHARMA, INC
11975 EL CAMINO REAL, SUITE 101
SAN DIEGO
CA
92130
1
0
0
0
Common stock, par value $0.00000002 per share
2012-05-11
4
X
0
236
5.34
A
654
D
Subscription rights (right to buy)
2.67
2012-05-11
4
X
0
2834
0
D
2012-03-30
2012-05-11
Units to purchase common stock and warrants
2834
0
D
Warrants to purchase common stock, par value $0.00000002
7.14
2012-05-11
4
X
0
2834
7.14
A
2012-05-11
2017-05-10
Common stock
118
2834
D
The number of securities and price reported previously have been adjusted for the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012.
This form is being filed to correct the cumulative number of shares owned by the reporting person, which was incorrectly reported due an administrative error.
The shares of common stock, par value $0.00000002 per share ("Common Stock") and warrants to purchase Common Stock were acquired in connection with the MEI Pharma, Inc. (the "Company") rights offering, the subscription period for which expired on May 11, 2012. In the rights offering, the Company distributed to its shareholders and holders of its Series A warrants, on a pro rata basis, subscription rights for the purchase of units. Each unit consisted of 0.0833 shares of the Company's Common Stock and warrants to purchase an additional 0.04167 shares of Common Stock at an exercise price of $7.14 per share. The subscription price for each unit was $2.67 (or $5.34 for two units representing one whole share of Common Stock). The reporting person exercised subscription rights for an aggregate of 2,834 units. Accordingly, upon the closing of the rights offering, the Company issued to the reporting person 236 shares of Common Stock and warrants to purchase an additional 118 shares.
/s/ William D. Rueckert
2013-09-12